Page last updated: 2024-08-22

ornithylaspartate and Hepatitis C, Chronic

ornithylaspartate has been researched along with Hepatitis C, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bogomolov, PO; Buyeverov, AO; Matsievich, MV; Mayev, IV; Uvarova, OV1
Koczorek, M1

Other Studies

2 other study(ies) available for ornithylaspartate and Hepatitis C, Chronic

ArticleYear
Possibilities of therapeutic correction of hyperammonemia and minimal hepatic encephalopathy in patients with chronic hepatitis C at the pre-cirrhotic stage.
    Terapevticheskii arkhiv, 2019, Mar-18, Volume: 91, Issue:2

    Topics: Adult; Ammonia; Case-Control Studies; Dipeptides; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Hyperammonemia; Male; Treatment Outcome

2019
[Chronic liver diseases. The nihilism has gone].
    MMW Fortschritte der Medizin, 2001, Dec-13, Volume: 143, Issue:51-52

    Topics: Amantadine; Antioxidants; Antiviral Agents; Chronic Disease; Dipeptides; Drug Therapy, Combination; Flumazenil; GABA Modulators; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Diseases; Pentoxifylline; Phosphodiesterase Inhibitors; Prospective Studies; Protective Agents; Ribavirin; Silymarin

2001